Generate a tailored SOP for Dr. Igor Stagljar. Improve your application with a focused, well-structured draft.
Igor Stagljar is a Professor in Molecular Genetics at the University of Toronto, where he directs significant proteomics projects focused on integral membrane proteins. His research encompasses cancer, drug discovery, proteomics, signalling, and technology development. He is recognized for his innovative work in identifying novel membrane protein-protein interaction therapeutic targets and screening novel drugs aimed at lung cancer. Stagljar's lab has also developed the SATiN serological test for COVID-19, a sensitive method for measuring coronavirus antibodies in the blood, utilizing modified luciferase for enhanced detection. He has collaborated with leading clinicians and scientists to advance research in cancer and COVID-19 health issues. Stagljar has made outstanding contributions to the field of Biology, evidenced by his multiple awards, including the EMBO Young Principal Investigator Award and the Inventor of the Year Award from the University of Toronto. He is a member of the Croatian Academy of Arts and Sciences and has co-founded biotech companies such as Dualsystems Biotech Inc. and Perturba Therapeutix Inc.
University of Toronto • Toronto, Ontario, Canada
Leading research in Molecular Genetics and directing significant proteomics projects.
Department of Sociology